Enrestec Statistics

Total Valuation

Enrestec has a market cap or net worth of TWD 5.63 billion. The enterprise value is 6.70 billion.

Market Cap	5.63B
Enterprise Value	6.70B

Important Dates

The next estimated earnings date is Friday, April 18, 2025.

Earnings Date	Apr 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Enrestec has 102.10 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	102.10M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	33.49%
Owned by Institutions (%)	n/a
Float	43.44M

Valuation Ratios

The trailing PE ratio is 89.68.

PE Ratio	89.68
Forward PE	n/a
PS Ratio	14.57
PB Ratio	5.93
P/TBV Ratio	6.19
P/FCF Ratio	699.80
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 55.36, with an EV/FCF ratio of 833.75.

EV / Earnings	106.85
EV / Sales	17.36
EV / EBITDA	55.36
EV / EBIT	217.63
EV / FCF	833.75

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.48.

Current Ratio	1.09
Quick Ratio	0.79
Debt / Equity	0.48
Debt / EBITDA	5.80
Debt / FCF	87.33
Interest Coverage	2.12

Financial Efficiency

Return on equity (ROE) is 0.04% and return on invested capital (ROIC) is 0.92%.

Return on Equity (ROE)	0.04%
Return on Assets (ROA)	0.87%
Return on Invested Capital (ROIC)	0.92%
Return on Capital Employed (ROCE)	1.54%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.17
Inventory Turnover	5.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.26% in the last 52 weeks. The beta is 0.01, so Enrestec's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	+13.26%
50-Day Moving Average	57.03
200-Day Moving Average	58.83
Relative Strength Index (RSI)	43.73
Average Volume (20 Days)	25,851

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enrestec had revenue of TWD 386.20 million and earned 62.73 million in profits. Earnings per share was 0.61.

Revenue	386.20M
Gross Profit	96.46M
Operating Income	30.80M
Pretax Income	-5.86M
Net Income	62.73M
EBITDA	119.61M
EBIT	30.80M
Earnings Per Share (EPS)	0.61

Full Income Statement

Balance Sheet

The company has 133.13 million in cash and 702.07 million in debt, giving a net cash position of -568.95 million or -5.57 per share.

Cash & Cash Equivalents	133.13M
Total Debt	702.07M
Net Cash	-568.95M
Net Cash Per Share	-5.57
Equity (Book Value)	1.46B
Book Value Per Share	9.30
Working Capital	23.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 97.33 million and capital expenditures -89.29 million, giving a free cash flow of 8.04 million.

Operating Cash Flow	97.33M
Capital Expenditures	-89.29M
Free Cash Flow	8.04M
FCF Per Share	0.08

Full Cash Flow Statement

Margins

Gross margin is 24.98%, with operating and profit margins of 7.97% and 16.24%.

Gross Margin	24.98%
Operating Margin	7.97%
Pretax Margin	-1.52%
Profit Margin	16.24%
EBITDA Margin	30.97%
EBIT Margin	7.97%
FCF Margin	2.08%

Dividends & Yields

Enrestec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.12%
FCF Yield	0.14%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Enrestec has an Altman Z-Score of 3.92.

Altman Z-Score	3.92
Piotroski F-Score	n/a